Ardelyx Shares Fall After Missing Profit Expectations

Dow Jones02-21

By Katherine Hamilton

 

Ardelyx shares fell after the company missed analysts' expectations that it would post a profit.

The stock fell 13% to $5.89 Friday. Shares are still up 2% over the past 12 months.

The biopharmaceutical company recorded a loss of $407,000 in the fourth quarter, which came out to be breaking even on a per-share basis.

Analysts polled by FactSet had been expecting net income of $4,500, or one cent a share.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

February 20, 2026 13:38 ET (18:38 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment